Locations

Baltimore, Maryland, USA

Johns Hopkins, Center for Psychedelic & Consciousness Research • University of Maryland, Baltimore • Center for Translational Medicine (CTM), University of Maryland School of Pharmacy • Johns Hopkins University • Bmore Psychedelic Society

Catalio Capital Management • Camden

Jason Williams

Psychedelic Session Guide / Facilitator • Research Program Supervisor

A Study of Psilocybin for Major Depressive Disorder (MDD) • Effects of Psilocybin in Anorexia Nervosa • Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease • Persisting Effects of Psilocybin • The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. • An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) • Effects of Psilocybin in Major Depressive Disorder • Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study • Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion • The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators • Psychopharmacology of Psilocybin in Cancer Patients • Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators • Psilocybin and Spiritual Practice • Effects of Hallucinogens and Other Drugs on Mood and Performance • Neurobiology and Pharmacokinets of Acute MDMA Administration • The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. • RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain • Ketamine for Treatment of MS Fatigue • ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) • Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine) • Pharmacokinetics of Antiepileptics in Patients on CRRT • Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients • Physiological, Behavioral and Subjective Effects of Drugs (GHB) • Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder • The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation • Effects of Psilocybin in Post-Treatment Lyme Disease • Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought

Bethesda, Maryland, USA

National Institute on Drug Abuse (NIDA) • National Institute of Neurological Disorders and Stroke (NINDS) • National Institutes of Health Clinical Center (CC) • National Institute on Minority Health and Health Disparities (NIMHD) • National Institutes of Health (NIH) • National Institute of Mental Health (NIMH) • National Cancer Institute (NCI) • National Institute of General Medical Sciences (NIGMS) • National Institute of Nursing Research (NINR) • Mid-Atlantic Epilepsy and Sleep Center, LLC • National Center for Research Resources (NCRR) • National Institute on Deafness and Other Communication Disorders (NIDCD) • National Institute on Aging (NIA) • Walter Reed National Military Medical Center • Cannabics Pharmaceuticals

Evaluating Ketamine and Psychological Sequelae • Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain • A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue • Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder • Mechanism of Action Underlying Ketamine s Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression • Effect of Ketamine on Fatigue Following Cancer Therapy • Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus • Rapid Antidepressant Effects of Ketamine in Major Depression • Neurobiology of Suicide

Bowie, Maryland, USA

Sarah Ortiz

Cheverly, Maryland, USA

Rebecca Quigley

Chevy Chase, Maryland, USA

Vitality Medical Infusions

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Cockeysville, Maryland, USA

Baltimore Ketamine Clinic

College Park, Maryland, USA

University of Maryland, College Park

Elkton, Maryland, USA

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

Ellicott City, Maryland, USA

Jessica Faulkner, CD(DONA)

Fort Detrick, Maryland, USA

Congressionally Directed Medical Research Programs

Gaithersburg, Maryland, USA

Ketamine for Major Depressive Disorder

Maryland, USA

Stacey Lehn • Stephanie Lewis • Jessica Smith • Kerri Gaither • Crystal Forman • Shanna Rathbone • Pam Hinshaw • Eugenia Argote • Nora Jean Banner • Christie Vetter • Davon L McCormick • Alyson Abramson • Ayoub Abdelmoula • leila kiani • Katie Hussong • Claudia Reshetiloff • Diana Marsellas • Nicole Ball • Marietta Amatangelo, MSc, RDN, LDN • Angela Atkins • Dianne Racek • Ilana Posner • Carson Whitaker • Heather Frantz • Lynnette Baxter • Julie Stevens

Pasadena, Maryland, USA

Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery

Potomac, Maryland, USA

Sunstone Therapies

Rockville, Maryland, USA

The Emmes Company, LLC • Defense and Veterans Center for Integrative Pain Management • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aquilino Cancer Center

A Study of Ketamine in Patients With Treatment-resistant Depression • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia. • The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

SilverSpring, Maryland, USA

WholePersonCare

Sparks, Maryland, USA

Baltimore Ketamine Clinic

Towson, Maryland, USA

Sheppard Pratt Health System

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy